Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy

Efficacy evaluation of 188Re-human serum albumin microsphere in hepatoma model

Liang-Cheng Chen, Wan-Chi Lee, Chung-Li Ho, Hsiao-Chiang Ni, Su-Jung Chen, Chih-Hsien Chang and Te-Wei Lee
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1490;
Liang-Cheng Chen
1Institute of Nuclear Energy Research, Taoyuan County, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wan-Chi Lee
1Institute of Nuclear Energy Research, Taoyuan County, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chung-Li Ho
1Institute of Nuclear Energy Research, Taoyuan County, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hsiao-Chiang Ni
1Institute of Nuclear Energy Research, Taoyuan County, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Su-Jung Chen
1Institute of Nuclear Energy Research, Taoyuan County, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chih-Hsien Chang
1Institute of Nuclear Energy Research, Taoyuan County, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Te-Wei Lee
1Institute of Nuclear Energy Research, Taoyuan County, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1490

Objectives The aim of this study was to investigate the efficacy evaluation of intraarterially administrated 188Re-human serum albumin microsphere (188Re-HSAM) in the GP7TB hepatoma rat model.

Methods Male F344 rats were intrahepatic inoculation with GP7TB 1 mm3 cubes. These studies were performed on rat at 26 d after tumor inoculation. The efficacy of 188Re-HSAM was performed by a single-dose treatment in GP7TB hepatoma rat via intraarterial route. Rats were checked for survival every day until death. The body weight was measured once a week.

Results In efficacy study, the median survival time for the rat, which received normal saline was 80 d. The median survival times for the mice treated with 10 mCi, 4.8 mCi and 2.9 mCi of 188Re-HSAM were 130 d (P = 0.003), 90.25 d (P = 0.035) and 83.5 d (P = 0.617), respectively. The increase in life span of 10 mCi, 4.8 mCi and 2.9 mCi of 188Re-HSAM were 62.5%, 12.8% and 4.4%, respectively.

Conclusions The therapeutic studies of 188Re-HSAM demonstrated better survival time and therapeutic efficacy for rat with increased dose in the GP7TB hepatoma model. These results suggested that intraarterial administration of 188Re-HSAM could provide a benefit and promising strategy for delivery of radiotherapeutics in oncology applications.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Efficacy evaluation of 188Re-human serum albumin microsphere in hepatoma model
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Efficacy evaluation of 188Re-human serum albumin microsphere in hepatoma model
Liang-Cheng Chen, Wan-Chi Lee, Chung-Li Ho, Hsiao-Chiang Ni, Su-Jung Chen, Chih-Hsien Chang, Te-Wei Lee
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1490;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Efficacy evaluation of 188Re-human serum albumin microsphere in hepatoma model
Liang-Cheng Chen, Wan-Chi Lee, Chung-Li Ho, Hsiao-Chiang Ni, Su-Jung Chen, Chih-Hsien Chang, Te-Wei Lee
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1490;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy

  • Lesion detection and workflow optimization in whole body diffusion MR imaging using trimodality PET/CT+MR in the oncology setting.
  • What is the impact of 18F-FDG PET/CT in the management of iodine positive metastatic differentiated thyroid cancer.
  • Analysis of the 131I therapy in the young and adolescent patients with differentiated thyroid carcinoma
Show more Oncology: Basic, Translational & Therapy

MTA I: Radiopharmaceutical Therapy Posters

  • Imaging and biochemical predictive biomarkers of overall survival and treatment response in patients receiving 223Ra-dichloride treatment in clinical practice
  • SUVmax of the FDG-avid metastatic lesions before I-131 therapy for differentiated thyroid carcinoma is a powerful independent prognostic factor
  • Long-term outcomes of 125 patients with stage IV pheochromocytoma or paraganglioma treated with 131I-MIBG
Show more MTA I: Radiopharmaceutical Therapy Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire